Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Payables (2022 - 2026)

Rallybio's Payables history spans 4 years, with the latest figure at $126000.0 for Q4 2025.

  • On a quarterly basis, Payables fell 54.68% to $126000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $126000.0, a 54.68% decrease, with the full-year FY2025 number at $126000.0, down 54.68% from a year prior.
  • Payables hit $126000.0 in Q4 2025 for Rallybio, down from $269000.0 in the prior quarter.
  • Over the last five years, Payables for RLYB hit a ceiling of $1.2 million in Q2 2024 and a floor of $119000.0 in Q2 2025.
  • Historically, Payables has averaged $576000.0 across 4 years, with a median of $470000.0 in 2024.
  • Biggest five-year swings in Payables: surged 76.78% in 2024 and later plummeted 90.23% in 2025.
  • Tracing RLYB's Payables over 4 years: stood at $1.1 million in 2022, then dropped by 12.39% to $976000.0 in 2023, then crashed by 71.52% to $278000.0 in 2024, then crashed by 54.68% to $126000.0 in 2025.
  • Business Quant data shows Payables for RLYB at $126000.0 in Q4 2025, $269000.0 in Q3 2025, and $119000.0 in Q2 2025.